Eliminating Cholera Transmission in Haiti

Affiliations

¹ From the Division of Global Health Equity, Brigham and Women's Hospital, Boston; and the Special Consulting Group to the Minister of Health and Population of Haiti, Port-au-Prince. The other members of the Special Consulting Group were Dr. Daphnee Delsoin Benoit, the Honorable Minister of Health and Population, Port-au-Prince, Haiti; Dr. Dennis Chao, Institute for Disease Modeling, Bellevue, WA; Dr. Donald Francois, Ministry of Health and Population, Port-au-Prince, Haiti; Dr. Jeannot Francois, Director of Expanded Program on Immunization, Ministry of Health and Population, Port-au-Prince, Haiti; Dr. Roger Glass, Fogarty International Center, National Institutes of Health (NIH), Bethesda, MD; Dr. Robert Hall, National Institute of Allergy and Infectious Diseases, NIH; Dr. Jerome H. Kim, International Vaccine Institute, Seoul, South Korea; Dr. Bernard Liautaud, Ministry of Health, Port-au-Prince, Haiti; Prof. Ira Longini, University of Florida, Gainesville; Ms. Helen Matzger, Bill and Melinda Gates Foundation, Seattle; Dr. Vittal Mogasale, International Vaccine Institute, Seoul, South Korea; Prof. Glenn Morris, University of Florida, Gainesville; Prof. Jean W. Pape, Weill Cornell Medical College, New York; Prof. David Sack, Johns Hopkins University, Baltimore; and Dr. Jordan Tappero, Centers for Disease Control and Prevention, Atlanta.

Louise C Ivers. N Engl J Med. 2017.

. 2017 Jan 12;376(2):101-103.

doi: 10.1056/NEJMp1614104. Epub 2016 Dec 7.

¹ From the Division of Global Health Equity, Brigham and Women's Hospital, Boston; and the Special Consulting Group to the Minister of Health and Population of Haiti, Port-au-Prince. The other members of the Special Consulting Group were Dr. Daphnee Delsoin Benoit, the Honorable Minister of Health and Population, Port-au-Prince, Haiti; Dr. Dennis Chao, Institute for Disease Modeling, Bellevue, WA; Dr. Donald Francois, Ministry of Health and Population, Port-au-Prince, Haiti; Dr. Jeannot Francois, Director of Expanded Program on Immunization, Ministry of Health and Population, Port-au-Prince, Haiti; Dr. Roger Glass, Fogarty International Center, National Institutes of Health (NIH), Bethesda, MD; Dr. Robert Hall, National Institute of Allergy and Infectious Diseases, NIH; Dr. Jerome H. Kim, International Vaccine Institute, Seoul, South Korea; Dr. Bernard Liautaud, Ministry of Health, Port-au-Prince, Haiti; Prof. Ira Longini, University of Florida, Gainesville; Ms. Helen Matzger, Bill and Melinda Gates Foundation, Seattle; Dr. Vittal Mogasale, International Vaccine Institute, Seoul, South Korea; Prof. Glenn Morris, University of Florida, Gainesville; Prof. Jean W. Pape, Weill Cornell Medical College, New York; Prof. David Sack, Johns Hopkins University, Baltimore; and Dr. Jordan Tappero, Centers for Disease Control and Prevention, Atlanta.

No abstract available

References

1. Cravioto A, Lanata CF, Lantagne DS, Nair B. Final Report of the Independent Panel of Experts on the Cholera Outbreak in Haiti. 2012
1. Jenson D, Szabo V, Duke FHIHHLSRT. Cholera in Haiti and other Caribbean regions, 19th century. Emerg Infect Dis. 2011;17:2130–5. - PMC - PubMed
1. Barzilay EJ, Schaad N, Magloire R, et al. Cholera surveillance during the Haiti epidemic--the first 2 years. The New England journal of medicine. 2013;368:599–609. - PubMed
1. United Nations Office for the Coordination of Humanitarian Affairs. Haiti: Hurricane Matthew. 2016.
1. World Health Organization. Cholera. Geneva: WHO; 2015.